DAVITA INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 128.3 USD | +1.73% |
|
-1.56% | +22.55% |
| Apr. 10 | Davita Announces Dennis Pullin to Its Board of Directors | CI |
| Mar. 13 | Transcript : DaVita Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:00 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows:
- supply of dialysis services (95.3%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2023, services are insured through 2,675 dialysis centers serving nearly 200,800 patients in the United States, and through 367 dialysis centers serving nearly 49,400 patients abroad;
- other (4.7%).
Calendar
2024-05-02
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
126.1
USD
Average target price
130.6
USD
Spread / Average Target
+3.55%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.55% | 11.06B | |
| -11.65% | 87.46B | |
| +12.80% | 78.56B | |
| +10.85% | 29.37B | |
| -11.65% | 16.78B | |
| -4.17% | 16.01B | |
| -6.74% | 13.98B | |
| +0.92% | 12.31B | |
| -30.35% | 12.07B | |
| 0.00% | 11.06B |
- Stock Market
- Equities
- DVA Stock
- News DaVita Inc.
- DaVita : Expands Use of Fresenius Medical Care's NxStage Home Hemodialysis Machine
